Skip to main content

Table 2 The comparison results of baseline laboratory parameters between the CSFP group and the non-CSFP group

From: Comparison of TyG and modified TyG indices in predicting coronary slow flow phenomenon

Variables

Non-CSFP group (n = 586)

CSFP group (n = 69)

Statistic

P

WBC, 109/L, M (Q₁, Q₃)

6.55 (5.40, 7.68)

6.20 (4.95, 7.54)

Z=-1.71

0.088

RBC, 1012/L, M (Q₁, Q₃)

4.46 (4.11, 4.76)

4.50 (4.17, 4.70)

Z=-0.13

0.896

PLT, 109/L, M (Q₁, Q₃)

219.00 (184.00, 256.00)

208.00 (160.00, 249.00)

Z=-1.96

0.050

ALT, U/L, M (Q₁, Q₃)

19.40 (14.30, 27.70)

22.10 (15.10, 31.60)

Z=-1.43

0.153

AST, U/L, M (Q₁, Q₃)

19.00 (16.30, 24.00)

21.10 (17.30, 25.80)

Z=-2.22

0.026

Albumin, g/L, M (Q₁, Q₃)

39.60 (37.90, 41.30)

39.40 (37.50, 41.40)

Z=-0.78

0.438

Fasting glucose, mmol/L, M (Q₁, Q₃)

5.47 (4.87, 6.48)

5.18 (4.77, 5.83)

Z=-1.33

0.182

eGFR, ml/min, M (Q₁, Q₃)

100.96 (87.75, 110.32)

99.33 (91.83, 108.06)

Z=-0.24

0.812

UA, mmol/L, M (Q₁, Q₃)

337.20 (283.18, 402.45)

384.90 (308.90, 443.70)

Z=-3.12

0.002

TG, mmol/L, M (Q₁, Q₃)

1.39 (1.01, 2.07)

1.66 (1.12, 2.45)

Z=-2.38

0.017

TC, mmol/L, M (Q₁, Q₃)

3.63 (3.12, 4.39)

3.86 (3.32, 4.63)

Z=-2.41

0.016

HDL-C, mmol/L, M (Q₁, Q₃)

1.13 (0.98, 1.31)

1.16 (1.01, 1.33)

Z=-0.63

0.526

LDL-C, mmol/L, M (Q₁, Q₃)

1.94 (1.52, 2.60)

2.18 (1.80, 2.99)

Z=-2.74

0.006

ApoA1, mmol/L, M (Q₁, Q₃)

1.29 (1.16, 1.46)

1.31 (1.15, 1.44)

Z=-0.03

0.976

ApoB1, mmol/L, M (Q₁, Q₃)

0.70 (0.58, 0.86)

0.76 (0.66, 0.95)

Z=-2.42

0.016

HCY, mmol/L, M (Q₁, Q₃)

12.28 (9.98, 15.75)

14.13 (11.21, 20.86)

Z=-3.45

< 0.001

HbA1C, %, M (Q₁, Q₃)

6.20 (5.80, 7.00)

6.10 (5.80, 6.60)

Z=-1.28

0.200

BNP, pg/ml, M (Q₁, Q₃)

42.45 (20.18, 97.87)

241.70 (166.90, 329.60)

Z=-10.86

< 0.001

TyG, M (Q₁, Q₃)

8.73 ± 0.63

9.03 ± 0.61

t=-3.84

< 0.001

TyG-WC, M (Q₁, Q₃)

834.09 (770.57, 903.21)

918.96 (832.54, 997.66)

Z = -5.83

< 0.001

TyG-BMI, M (Q₁, Q₃)

222.17 ± 38.36

241.56 ± 38.69

t=-3.97

< 0.001

TyG-WHR, M (Q₁, Q₃)

5.0(4.6, 5.4)

5.5 (5.1, 5.8)

Z = -5.59

< 0.001

  1. Abbreviation: CSFP: coronary slow flow phenomenal; ALT: alanine aminotransferase; AST: aspartate transaminase; eGFR: estimated glomerular filtration rate; UA: uric acid; TC: total cholesterol; TG: triglyceride; HDL-C: high-density lipoprotein cholesterol; LDL-C: low-density lipoprotein cholesterol; Apo: apolipoprotein; HCY: homocysteine; HbA1C: Glycosylated Hemoglobin, Type A1C; BNP: B-type natriuretic peptide; TyG: triglyceride-glucose ratio; TyG-WC: triglyceride-glucose ratio-waist circumference; TyG-BMI: triglyceride-glucose ratio- body weight index; TyG-WHR: riglyceride-glucose ratio-weight height ratio